top of page

PREVENAR 20 SUSPENSION FOR INJECTION IN SINGLE-DOSE PRE-FILLED SYRINGE 0.5ML

Product details

Registration number: SIN16648P

Classification: Prescription Only

Active ingredients:

  • CRM197 protein
  • Pneumococcal polysaccharide serotype 1 (conjugate)
  • Pneumococcal polysaccharide serotype 10A (conjugate)
  • Pneumococcal polysaccharide serotype 11A (conjugate)
  • Pneumococcal polysaccharide serotype 12F (conjugate)
  • Pneumococcal polysaccharide serotype 14 (conjugate)
  • Pneumococcal polysaccharide serotype 15B (conjugate)
  • Pneumococcal polysaccharide serotype 18C (conjugate)
  • Pneumococcal polysaccharide serotype 19A (conjugate)
  • Pneumococcal polysaccharide serotype 19F (conjugate)
  • Pneumococcal polysaccharide serotype 22F (conjugate)
  • Pneumococcal polysaccharide serotype 23F (conjugate)
  • Pneumococcal polysaccharide serotype 3 (conjugate)
  • Pneumococcal polysaccharide serotype 33F (conjugate)
  • Pneumococcal polysaccharide serotype 4 (conjugate)
  • Pneumococcal polysaccharide serotype 5 (conjugate)
  • Pneumococcal polysaccharide serotype 6A (conjugate)
  • Pneumococcal polysaccharide serotype 6B (conjugate)
  • Pneumococcal polysaccharide serotype 7F (conjugate)
  • Pneumococcal polysaccharide serotype 8 (conjugate)
  • Pneumococcal polysaccharide serotype 9V (conjugate)

Strength:

  • Approx. 51 μg/0.5ml
  • 2.2 μg/0.5ml
  • 2.2 μg/0.5ml
  • 2.2 μg/0.5ml
  • 2.2 μg/0.5ml
  • 2.2 μg/0.5ml
  • 2.2 μg/0.5ml
  • 2.2 μg/0.5ml
  • 2.2 μg/0.5ml
  • 2.2 μg/0.5ml
  • 2.2 μg/0.5ml
  • 2.2 μg/0.5ml
  • 2.2 μg/0.5ml
  • 2.2 μg/0.5ml
  • 2.2 μg/0.5ml
  • 2.2 μg/0.5ml
  • 2.2 μg/0.5ml
  • 4.4 μg/0.5ml
  • 2.2 μg/0.5ml
  • 2.2 μg/0.5ml
  • 2.2 μg/0.5ml

Dosage form: INJECTION, SUSPENSION

Route: INTRAMUSCULAR

Registrant: PFIZER PRIVATE LIMITED

ATC code: J07AL02

HSA approval date: 30 November 2022

Manufacturer(s): Pfizer Ireland Pharmaceuticals Unlimited Company

Manufacturing country/countries: IRELAND

What are the HSA registration number and classification for PREVENAR 20 SUSPENSION FOR INJECTION IN SINGLE-DOSE PRE-FILLED SYRINGE 0.5ML?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN16648P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for PREVENAR 20 SUSPENSION FOR INJECTION IN SINGLE-DOSE PRE-FILLED SYRINGE 0.5ML?

According to the HSA dataset updated 7 August 2026:

Active ingredients:

  • CRM197 protein
  • Pneumococcal polysaccharide serotype 1 (conjugate)
  • Pneumococcal polysaccharide serotype 10A (conjugate)
  • Pneumococcal polysaccharide serotype 11A (conjugate)
  • Pneumococcal polysaccharide serotype 12F (conjugate)
  • Pneumococcal polysaccharide serotype 14 (conjugate)
  • Pneumococcal polysaccharide serotype 15B (conjugate)
  • Pneumococcal polysaccharide serotype 18C (conjugate)
  • Pneumococcal polysaccharide serotype 19A (conjugate)
  • Pneumococcal polysaccharide serotype 19F (conjugate)
  • Pneumococcal polysaccharide serotype 22F (conjugate)
  • Pneumococcal polysaccharide serotype 23F (conjugate)
  • Pneumococcal polysaccharide serotype 3 (conjugate)
  • Pneumococcal polysaccharide serotype 33F (conjugate)
  • Pneumococcal polysaccharide serotype 4 (conjugate)
  • Pneumococcal polysaccharide serotype 5 (conjugate)
  • Pneumococcal polysaccharide serotype 6A (conjugate)
  • Pneumococcal polysaccharide serotype 6B (conjugate)
  • Pneumococcal polysaccharide serotype 7F (conjugate)
  • Pneumococcal polysaccharide serotype 8 (conjugate)
  • Pneumococcal polysaccharide serotype 9V (conjugate)

Strength:

  • Approx. 51 μg/0.5ml
  • 2.2 μg/0.5ml
  • 2.2 μg/0.5ml
  • 2.2 μg/0.5ml
  • 2.2 μg/0.5ml
  • 2.2 μg/0.5ml
  • 2.2 μg/0.5ml
  • 2.2 μg/0.5ml
  • 2.2 μg/0.5ml
  • 2.2 μg/0.5ml
  • 2.2 μg/0.5ml
  • 2.2 μg/0.5ml
  • 2.2 μg/0.5ml
  • 2.2 μg/0.5ml
  • 2.2 μg/0.5ml
  • 2.2 μg/0.5ml
  • 2.2 μg/0.5ml
  • 4.4 μg/0.5ml
  • 2.2 μg/0.5ml
  • 2.2 μg/0.5ml
  • 2.2 μg/0.5ml

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for PREVENAR 20 SUSPENSION FOR INJECTION IN SINGLE-DOSE PRE-FILLED SYRINGE 0.5ML?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION, SUSPENSION

Route: INTRAMUSCULAR

Source for this answer

Who is the recorded registrant for PREVENAR 20 SUSPENSION FOR INJECTION IN SINGLE-DOSE PRE-FILLED SYRINGE 0.5ML?

According to the HSA dataset updated 7 August 2026:

Registrant: PFIZER PRIVATE LIMITED

Source for this answer

Which manufacturers and countries are listed for PREVENAR 20 SUSPENSION FOR INJECTION IN SINGLE-DOSE PRE-FILLED SYRINGE 0.5ML?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s): Pfizer Ireland Pharmaceuticals Unlimited Company

Manufacturing country/countries: IRELAND

Source for this answer

Where can I look up PREVENAR 20 SUSPENSION FOR INJECTION IN SINGLE-DOSE PRE-FILLED SYRINGE 0.5ML in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN16648P or the exact product name PREVENAR 20 SUSPENSION FOR INJECTION IN SINGLE-DOSE PRE-FILLED SYRINGE 0.5ML. The general register link does not preselect this product.

Source for this answer

What are the source dates for this PREVENAR 20 SUSPENSION FOR INJECTION IN SINGLE-DOSE PRE-FILLED SYRINGE 0.5ML record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this PREVENAR 20 SUSPENSION FOR INJECTION IN SINGLE-DOSE PRE-FILLED SYRINGE 0.5ML record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN16648P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page